Abstract
Purpose
To assess the impact of weight loss on health-related quality-of-life (HRQL), to describe the factors associated with improvements in HRQL after weight loss, and to assess the relationship between obesity as assessed by body mass index (BMI) and HRQL before and after weight loss.
Methods
We studied 188 obese patients with BMI ≥ 32 kg/m2 with one or more comorbidities or ≥35 kg/m2. All patients had baseline and follow-up assessments of BMI and HRQL using the EuroQol (EQ-5D) and its visual analog scale (VAS) before and after 6 months of medical weight loss that employed very low-calorie diets, physical activity, and intensive behavioral counseling.
Results
At baseline, age was 50 ± 8 years (mean ± SD), BMI was 40. 0 ± 5.0 kg/m2, EQ-5D-derived health utility score was 0.85 ± 0.13, and VAS-reported quality-of-life was 0.67 ± 0.18. At 6-month follow-up, BMI decreased by 7.0 ± 3.2 kg/m2, EQ-5D increased by 0.06 [interquartile range (IQR) 0.06–0.17], and VAS increased by 0.14 (IQR 0.04–0.23). In multivariate analyses, improvement in EQ-5D and VAS were associated with lower baseline BMI, greater reduction in BMI at follow-up, fewer baseline comorbidities, and lower baseline HRQL. For any given BMI category, EQ-5D and VAS tended to be higher at follow-up than at baseline.
Conclusion
Measured improvements in HRQL between baseline and follow-up were greater than predicted by the reduction in BMI at follow-up. If investigators use cross-sectional data to estimate changes in HRQL as a function of BMI, they will underestimate the improvement in HRQL associated with weight loss and underestimate the cost-utility of interventions for obesity treatment.
Similar content being viewed by others
References
Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
EQ-5D-5L User Guide. Basic information on how to use the EQ-5D-5L instrument. Version 1.0 April 2011. http://www.euroqol.org/fileadmin/user_upload/Documenten/PDF/Folders_Flyers/UserGuide_EQ-5D-5L.pdf Accessed July 17, 2013.
Zhu, S. K., Wang, Z. M., Heshka, S., Heo, M., Faith, M. S., & Heymsfield, S. B. (2002). Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds. American Journal of Clinical Nutrition, 76, 743–749.
Wildman, R. P., Gu, D., Reynolds, K., Duan, X., & He, J. (2004). Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. American Journal of Clinical Nutrition, 80, 1129–1136.
WIN Weight-control Information Network. Overweight and obesity statistics. http://www.win.niddk.nih.gov/statistics/ Accessed July 19, 2013.
Rothberg, A. E., Peeters, A. & Herman, W. H. (In press). The cost-effectiveness of obesity prevention and treatment. In G. A. Bray & C. Bouchard (Eds.), Handbook of obesity Vol 2: Clinical applications 4th Edition (pp: In press). London, England: Informa Healthcare.
Doyle, S., Lloyd, A., Moore, L., Ray, J., & Gray, A. (2012). A systematic review and critical assessment of health state utilities. Weight change and type 2 diabetes mellitus. Pharmacoeconomics, 30, 1133–1143.
Kortt, M. A., & Dollery, B. (2011). Association between body mass index and health-related quality of life among an Australian sample. Clinical Therapeutics, 33, 1466–1474.
Dennett, S. L., Boye, K. S., & Yurgin, N. R. (2008). The impact of body weight on patient utilities with or without type 2 diabetes: A review of the medical literature. Value Health, 11, 478–486.
Craig, B. M., & Tseng, D. S. (2002). Cost-effectiveness of gastric bypass for severe obesity. American Journal of Medicine, 113, 491–498.
Hakim, Z., Wolf, A., & Garrison, L. P. (2002). Estimating the effect of changes in body mass index on health state preferences. Pharmacoeconomics, 20, 393–404.
Kortt, M. A., & Clarke, P. M. (2005). Estimating utility values for health states of overweight and obese individuals using the SF-36. Quality of Life Research, 14, 2177–2185.
Soltoft, F., Hammer, M., & Kragh, N. (2009). The association of body mass index and health-related quality of life in the general population: Data from the 2003 Health Survey of England. Quality of Life Research, 18, 1293–1299.
Trakas, K., Oh, P. I., Singh, S., et al. (2001). The health status of obese individuals in Canada. International Journal of Obesity and Related Metabolic Disorders, 25, 662–668.
Livingston, E. H., & Ko, C. Y. (2002). Use of the health and activities limitation index as a measure of quality of life in obesity. Obesity Research, 10, 824–832.
Groessl, E. J., Kaplan, R. M., Barrett-Connor, E., et al. (2004). Body mass index and quality of well-being in a community of older adults. American Journal of Preventive Medicine, 26, 126–129.
Macran, S. (2004). The relationship between body mass index and health-related quality of life. Centre for Health Economics: University of York.
Sach, T. H., Barton, G. R., Doherty, M., et al. (2007). The relationship between body mass index and health-related quality of life: Comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity (London), 31, 189–196.
Brennan, A., Ara, R., Sterz, R., et al. (2006). Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany. The European Journal of Health Economics, 7, 276–284.
Ara, R., & Brennan, A. (2007). The cost-effectiveness of sibutramine in non-diabetic obese patients: Evidence from four Western countries. Obesity Reviews, 8, 363–371.
Kolotkin, R. L., Norquist, J. M., Crosby, R. D., et al. (2009). One-year health-related quality of life outcomes in weight loss trial participants: Comparison of three measures. Health Qual Life Outcomes,. doi:10.1186/1477-7525-7-53.
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2012). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research,. doi:10.1007/s11136-012-0322-4.
Acknowledgments
The work was supported by Grant Number DK089503 (MNORC) and Grant Number P30DK092926 (MCDTR) from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. Additional support was provided by the A. Alfred Taubman Medical Institute and the Robert C. and Veronica Atkins Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rothberg, A.E., McEwen, L.N., Kraftson, A.T. et al. The impact of weight loss on health-related quality-of-life: implications for cost-effectiveness analyses. Qual Life Res 23, 1371–1376 (2014). https://doi.org/10.1007/s11136-013-0557-8
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0557-8